|
| 37100101 | Structural insight to elucidate the binding specificity of the anti-cortisol Fab fragment with glucocorticoids. | J Struct Biol | 2023 |
| 35642679 | Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancerâ¿¿Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling". | J Proteome Res | 2022 |
| 34259504 | Recombinant Peptide Mimetic NanoLuc Tracer for Sensitive Immunodetection of Mycophenolic Acid. | Anal Chem | 2021 |
| 30123424 | Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers. | Oncotarget | 2018 |
| 27760381 | High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability. | Gene | 2017 |
| 28451461 | <i>PLA2G7</i> associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells. | J Pathol Clin Res | 2017 |
| 28187790 | Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance. | Genome Med | 2017 |
| 26981633 | REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker. | PLoS One | 2016 |
| 27891324 | High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer. | J Mol Biochem | 2016 |
| 27531891 | Wnt signalling is a bi-directional vulnerability of cancer cells. | Oncotarget | 2016 |
| 26802024 | The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease. | Oncotarget | 2016 |
| 25359680 | Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions. | Int J Cancer | 2015 |
| 26673823 | Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma. | Oncotarget | 2015 |
| 26013405 | Isolation of Mal d 1 and Api g 1 - specific recombinant antibodies from mouse IgG Fab fragment libraries - Mal d 1-specific antibody exhibits cross-reactivity against Bet v 1. | BMC Biotechnol | 2015 |
| 24700756 | Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues. | J Histochem Cytochem | 2014 |
| 24833255 | Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients. | Oncotarget | 2014 |
| 23295955 | High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion. | Oncotarget | 2013 |
| 24086398 | FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion. | PLoS One | 2013 |
| 21919029 | Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer. | Prostate | 2012 |
| 23227212 | Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma. | PLoS One | 2012 |
| 23251544 | Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells. | PLoS One | 2012 |
| 22761906 | High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer. | PLoS One | 2012 |
| 22751924 | c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cells. | Mol Cell Biol | 2012 |
| 22546809 | Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery. | Genome Med | 2012 |
| 22308027 | Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling. | J Biol Chem | 2012 |
| 22215106 | Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. | Br J Cancer | 2012 |
| 22072156 | 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells. | J Pathol | 2012 |
| 22070544 | Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling. | J Proteome Res | 2012 |
| 22142811 | Differentiation-promoting culture of competent and noncompetent keratinocytes identifies biomarkers for head and neck cancer. | Am J Pathol | 2012 |
| 21281786 | Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. | Am J Pathol | 2011 |
| 22202492 | Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. | Oncotarget | 2011 |
| 21811097 | Function of ERBB4 is determined by alternative splicing. | Cell Cycle | 2011 |
| 21365010 | GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets. | PLoS One | 2011 |
| 21478550 | Large scale RNAi screen reveals that the inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiation. | J Biol Chem | 2011 |
| 21416608 | Stimulation of human embryonic stem cell-derived cardiomyocytes on thin-film microelectrodes. | Biotechnol J | 2011 |
| 21415164 | Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. | Cancer Res | 2011 |
| 20633255 | Characterization of Diaphanous-related formin FMNL2 in human tissues. | BMC Cell Biol | 2010 |
| 21082043 | Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2. | Neoplasia | 2010 |
| 21159605 | Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells. | Mol Cancer Ther | 2010 |
| 20713528 | FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. | Cancer Res | 2010 |
| 19123480 | Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1. | Int J Cancer | 2009 |
| 19825952 | Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance. | Clin Cancer Res | 2009 |
| 19789329 | High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. | Clin Cancer Res | 2009 |
| 18454307 | Role of ErbB4 in breast cancer. | J Mammary Gland Biol Neoplasia | 2008 |
| 18803840 | Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. | Genome Biol | 2008 |
| 18798265 | Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. | Int J Cancer | 2008 |
| 17079440 | TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. | Cancer Res | 2006 |
| 11973349 | Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. | J Cell Sci | 2002 |
| 12409319 | A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. | FASEB J | 2002 |
| 11416142 | Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. | Mol Cell Biol | 2001 |